Evaluation of blood glucose and serum lipids lowring effects of teneligliptin in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- Patients with type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000012206
- Lead Sponsor
- Wakayama medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1:contrandication to teneligliptin 2:Ineligible for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure, LDL-c
- Secondary Outcome Measures
Name Time Method HbA1c, blood glucose, u-Na, s-Na, s-Cr, u-Cr, NT-proBNP, IRI, ANP, sLDL, metylglyoxal, CRP